← Leaderboards
Keith Strand
University Of Colorado Denver
$53,273
Attributed
$53,273
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $32.1K · FY2019–20$50K$37.5K$25K$12.5K$0
'19
'20
Funding mix
By agency
NIH$53,273 · 1
By mechanism
F31$53,273 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Mary Cm Weiser-Evans$14,403,734
- Mark Robert Nicolls$22,256,364
- Tatiana G Kutateladze$17,515,896
- Kurt R Stenmark$22,132,904
- Maranke I. Koster$6,249,820
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAngiotensin IiAnimal ModelArterial Fatty StreakBaseBlood VesselsBromodomainCardiovascular DiseasesCardiovascular Disorder TherapyCardiovascular ModelsCause Of DeathCell Differentiation ProcessCell NucleusCellsCell TypeChemokineChromatinClinically RelevantComplexConnective TissueCoronary ArteryCountryCytokineAcetylation
Grant awards (2)
Pharmacologic PTEN upregulation: A novel therapeutic approach to prevent pathological vascular remodeling and fibrosis$21,132
F31 · FY2020 · HL · contact PI
Pharmacologic PTEN upregulation: A novel therapeutic approach to prevent pathological vascular remodeling and fibrosis$32,141
F31 · FY2019 · HL · contact PI